Osmessn.com

Challenges in Developing T Cell Engagers Ian Chan, CEO of Abpro, discusses the advantages of their DiversImmune and MultiMab platforms for antibody discovery and engineering. Abpro’s platform can create novel antibodies at industry-leading speeds, which are then reassembled into custom configurations for therapeutic purposes. They have developed bispecific antibodies, particularly T cell engagers for oncology, […]

James D. Chambers, PhD, MPharm, MSc James D. Chambers, PhD, MPharm, MSc, is a health economist by trade. After earning his MSc in Health Economics from the University of York and his doctorate in that same focus with Brunel University’s Health Economic Research Group, he has gone on to pursue various endeavors along that track, […]

In a video interview with Pharma Commerce, Laura Johnson, senior director of sales, life sciences, Loftware, discusses how supply chain collaboration is becoming increasingly important, particularly in the life sciences and pharmaceutical sectors. According to Johnson, the adoption of cloud-enabled collaborative supply chains is crucial for improving real-time data sharing. This enhances visibility and coordination […]

Image Credit: Adobe Stock Images/FreshIdea.com The FDA has approved an expanded access program that will provide an alternative for Tice BCG—a Merck medication that treats various types of bladder cancer—to patients in the United States.1 A rise in global demand has resulted in supply shortages of Tice BCG in the country, which have impacted the treatment […]

In a video interview with Pharma Commerce, Laura Johnson, senior director of sales, life sciences, Loftware, discusses how supply chain collaboration is becoming increasingly important, particularly in the life sciences and pharmaceutical sectors. According to Johnson, the adoption of cloud-enabled collaborative supply chains is crucial for improving real-time data sharing. This enhances visibility and coordination […]

Image Credit: Adobe Stock Images/AndrzejTokarski.com After revealing a plan in which the United States would match the tax rates of what trading partners also charge on imports (as a way to balance the trade scales),1 President Trump recently announced that that he would impose a tariff of 25% or higher on pharmaceuticals, according to Reuters.2 […]

Navigating Distrust: Pharma in the Age of Social Media Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, […]

Image Credit: Adobe Stock Images/Itsaree.com Many would agree that over the past five years or so, telehealth has skyrocketed in popularity, as another way to provide clinical healthcare, increasing access to mental health and managed care.1-4 Nevertheless, this is a double-edged sword—for all its benefits, the argument could also be made that telehealth could worsen […]

In a video interview with Pharma Commerce, Laura Johnson, senior director of sales, life sciences, Loftware, discusses how supply chain collaboration is becoming increasingly important, particularly in the life sciences and pharmaceutical sectors. According to Johnson, the adoption of cloud-enabled collaborative supply chains is crucial for improving real-time data sharing. This enhances visibility and coordination […]

The ChloraPrep Clear 1 mL Applicator. Image Credit: BD Becton, Dickinson and Company (BD), a medical technology (MedTech) company that produces and sells medical devices, laboratory equipment, and diagnostic products, is voluntarily recalling one lot of its ChloraPrep Clear 1 mL Applicators, due to fungal contamination.1 Under certain environmental conditions, the growth of Aspergillus penicillioides […]

In a video interview with Pharma Commerce, James Shehan, chair of the FDA Regulatory practice at Lowenstein Sandler, discusses the potential impact of upcoming tariffs on pharmaceutical supply chains, focusing on Canada, Mexico, and China. He believes that tariffs on Mexico and Canada would have minimal effects on supply chains, as the pharmaceutical industry sources […]

Mike Hennessy Jr., President and CEO, MJH Life Sciences 2025 is upon us, officially marking a quarter of a century since Y2K and the midpoint of the decade. There is no doubt that time does quickly fly by, and with that, the February issue of Pharmaceutical Commerce has arrived just as swiftly. The first edition […]

Pharmaceutical Commerce – February 2025 Issue (PDF) Beyond the GLP-1 Headlines Conference Connect: Navigating the Future of Pharma Trade 3PLs: From Resilience to Sustainability The Prominence of Pharmacy Deserts Breaking Point: How 2025 Will Reshape Patient Support Services M&A in Pharma: Balancing Growth and Risk Welcome to the ‘Dark Side’ Closing the Health Literacy and […]

PwC Report Identifies Top Trends in Pharma PwC report identifies transformative trends impacting the pharma market this year and into the future. As Use Becomes More Widespread, Counseling About Cannabis Use Is Crucial The trend toward higher-potency marijuana could pose additional, unknown risks. DOGE Cuts Pose Risk to Largest Government Contractors The Trump administration’s moves […]

How Pharma Can Effectively Combat Misinformation/Disinformation In this part of his Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, identifies strategies pharmaceutical companies can use to combat misinformation on social media. Partnering for Women’s Health: The Pharmacist’s Collaborative Role Panelists discuss how health care professionals collaborate through interdisciplinary teams, integrated care coordination, […]